Elisa Bertoli

558 total citations
32 papers, 344 citations indexed

About

Elisa Bertoli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Elisa Bertoli has authored 32 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Elisa Bertoli's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Elisa Bertoli is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Elisa Bertoli collaborates with scholars based in Italy, United States and Ukraine. Elisa Bertoli's co-authors include Elisa De Carlo, Alessandra Bearz, Alessandro Del Conte, Michele Spina, Brigida Stanzione, A. Michelotti, Alberto Revelant, Fabio Puglisi, Silvia Buriolla and Serge Masson and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Elisa Bertoli

30 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Bertoli Italy 11 205 175 82 79 30 32 344
Tomohiro Suzumura Japan 12 223 1.1× 163 0.9× 46 0.6× 87 1.1× 25 0.8× 36 349
Federica Pecci Italy 12 181 0.9× 285 1.6× 95 1.2× 98 1.2× 57 1.9× 61 442
Zhangzhou Huang China 8 106 0.5× 158 0.9× 71 0.9× 78 1.0× 40 1.3× 19 279
Yingjian Song China 10 133 0.6× 192 1.1× 99 1.2× 102 1.3× 46 1.5× 16 373
Amparo Sánchez-Gastaldo Spain 9 164 0.8× 168 1.0× 58 0.7× 141 1.8× 22 0.7× 28 367
Maedeh Barahman Iran 9 168 0.8× 106 0.6× 67 0.8× 130 1.6× 46 1.5× 31 357
Juan Zhou China 12 154 0.8× 122 0.7× 84 1.0× 144 1.8× 20 0.7× 19 383
Christina Guo United Kingdom 8 167 0.8× 129 0.7× 58 0.7× 111 1.4× 28 0.9× 26 350
Yunyan Wan China 10 141 0.7× 128 0.7× 81 1.0× 137 1.7× 51 1.7× 23 376
Daniele Marinelli Italy 10 98 0.5× 132 0.8× 91 1.1× 104 1.3× 57 1.9× 35 330

Countries citing papers authored by Elisa Bertoli

Since Specialization
Citations

This map shows the geographic impact of Elisa Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Bertoli more than expected).

Fields of papers citing papers by Elisa Bertoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Bertoli. The network helps show where Elisa Bertoli may publish in the future.

Co-authorship network of co-authors of Elisa Bertoli

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Bertoli. A scholar is included among the top collaborators of Elisa Bertoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Bertoli. Elisa Bertoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carlo, Elisa De, Elisa Bertoli, Brigida Stanzione, et al.. (2025). Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(2). 554–554. 2 indexed citations
2.
Bertoli, Elisa, Elisa De Carlo, Brigida Stanzione, et al.. (2025). Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches. International Journal of Molecular Sciences. 26(2). 583–583. 5 indexed citations
3.
Bearz, Alessandra, Elisa Bertoli, Brigida Stanzione, et al.. (2025). EML4-ALK: Update on ALK Inhibitors. International Journal of Molecular Sciences. 26(1). 308–308. 3 indexed citations
4.
Stanzione, Brigida, Alessandro Del Conte, Elisa Bertoli, et al.. (2025). Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies. Cancers. 17(9). 1515–1515. 2 indexed citations
5.
Carlo, Elisa De, Elisa Bertoli, Brigida Stanzione, et al.. (2024). Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance. International Journal of Molecular Sciences. 25(23). 12972–12972.
6.
Bertoli, Elisa, Elisa De Carlo, Marcella Montico, et al.. (2024). EP.12B.14 Platinum-Pemetrexed Chemotherapy and Lorlatinib Combination in Advanced ALK Positive NSCLC Progressing to Lorlatinib: A Case Series. Journal of Thoracic Oncology. 19(10). S646–S646.
7.
Carlo, Elisa De, Elisa Bertoli, Mónica Schiappacassi, et al.. (2024). Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC. Frontiers in Oncology. 14. 1307458–1307458. 1 indexed citations
8.
Bertoli, Elisa, Elisa De Carlo, Debora Basile, et al.. (2023). Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications. International Journal of Molecular Sciences. 24(13). 10803–10803. 12 indexed citations
9.
Stanzione, Brigida, Alessandro Del Conte, Elisa Bertoli, et al.. (2023). Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer. International Journal of Molecular Sciences. 24(14). 11495–11495. 12 indexed citations
10.
Michelotti, A., et al.. (2022). NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease. International Journal of Molecular Sciences. 23(12). 6748–6748. 19 indexed citations
11.
Michelotti, A., et al.. (2022). Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials. International Journal of Molecular Sciences. 23(13). 7222–7222. 46 indexed citations
12.
Targato, Giada, Elisa Bertoli, Claudia Andreetta, et al.. (2022). Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?. Frontiers in Oncology. 12. 885992–885992. 3 indexed citations
13.
Lisanti, C., Debora Basile, Silvio Ken Garattini, et al.. (2022). The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer. Cancers. 15(1). 175–175. 9 indexed citations
14.
Bearz, Alessandra, Elisa De Carlo, Alessandro Del Conte, et al.. (2022). The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation. International Journal of Molecular Sciences. 23(13). 7322–7322. 3 indexed citations
15.
Carlo, Elisa De, Elisa Bertoli, Alessandro Del Conte, et al.. (2022). Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era. International Journal of Molecular Sciences. 23(12). 6477–6477. 10 indexed citations
16.
Garattini, Silvio Ken, Debora Basile, Marta Bonotto, et al.. (2021). Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer. Cancers. 13(14). 3504–3504. 7 indexed citations
17.
Garutti, Mattia, Silvia Buriolla, Elisa Bertoli, et al.. (2020). “To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers. Cancers. 12(7). 1941–1941. 4 indexed citations
18.
Lisanti, C., Debora Basile, Elisa Bertoli, et al.. (2020). The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer. Journal of Geriatric Oncology. 11(8). 1268–1273. 9 indexed citations
19.
Bertoli, Elisa, Giada Targato, Maria Grazia Vitale, et al.. (2019). Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?. Annals of Oncology. 30. v78–v78. 1 indexed citations
20.
Bonotto, Marta, Lorenzo Gerratana, Giacomo Pelizzari, et al.. (2018). Association of clinical factors and biological subtypes with different Ca15-3 levels in metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e24014–e24014. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohiro Suzumura Breakdown of academic impact, for papers by Federica Pecci Breakdown of academic impact, for papers by Zhangzhou Huang Breakdown of academic impact, for papers by Yingjian Song Breakdown of academic impact, for papers by Amparo Sánchez-Gastaldo Breakdown of academic impact, for papers by Maedeh Barahman Breakdown of academic impact, for papers by Juan Zhou Breakdown of academic impact, for papers by Christina Guo Breakdown of academic impact, for papers by Yunyan Wan Breakdown of academic impact, for papers by Daniele Marinelli
Rankless by CCL
2026